ScholarGate
Get started

Method evidence record

EASI

The EASI is a structured, clinician-administered tool for assessing the extent and intensity of atopic dermatitis across the body. Developed by Hanifin and colleagues in 2001, it divides the body into four regions with weighted area factors, ensuring proportional contribution to total score. EASI has become the primary objective severity measure in atopic dermatitis clinical trials and is recommended by international regulatory authorities (FDA, EMA).

Evidence statusSources recorded, not reviewedBibliographic sources are present. Claim-level evidence review has not been performed.

Source record

Recorded

Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.

Eczema Area and Severity Index

Taxonomic method recordprocess-pipelinedermatology

  1. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 2001;10(1):11-18. · DOI 10.1034/j.1600-0625.2001.100102.x

  2. Stalder JF, Taïeb A. Therapeutic classification of atopic dermatitis. Arch Dermatol. 2003;139(9):1221-1222. · URL

Open full method2 recorded citations, copied from the method source record.

Curated claims

Assessed

Claims persisted in the evidence ledger, each with its own assessment.

No curated claims yet

This view does not invent a claim assessment when the ledger has none.

Related methods

Suggested2

Generated from the method graph and shown as machine-suggested relations. No evidence claim is inferred.